Aquestive Therapeutics Inc investor relations material
Listen to the latest call from Aquestive Therapeutics Inc
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company develops drugs for serious or life-threatening illnesses with unmet need by utilizing its chemistry expertise of developing enzyme inhibitors. It offers lead product ABT-199, which is a potent inhibitor against two enzymes involved in virus replication; and candidates that are being developed for the treatment of disorders related to protein misfolding. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.
Ticker
AQSTCountry
USAbout
IR-page